Clinical Trial Update: Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety and potential sensitisation risk of repeated intradermal administration of the rdESAT-6 + rCFP-10 skin test for tuberculos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• rdESAT-6 + rCFP-10 skin test (rdESAT-6 and rCFP-10 intradermal skin test)

Snippet

Sponsor: Statens Serum Institut | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED